Raised Icp In Children

Disclaimer: This document provides general medical information for educational purposes only and does not constitute medical advice. It is intended for use by healthcare professionals as a reference. Clinical decisions must always be made based on the individual patient's condition, clinical judgment, and in consultation with specialists as appropriate. Always refer to the latest evidence-based guidelines and local protocols.

Overview

• Definition: Intracranial pressure (ICP) is the pressure exerted by the contents (brain parenchyma, cerebrospinal fluid [CSF], and blood) within the rigid confines of the skull. Raised ICP (intracranial hypertension) occurs when this pressure exceeds normal physiological limits. In children, normal ICP varies with age, typically <10-15 mmHg in infants/young children and <20 mmHg in older children/adolescents when measured in the supine position. Sustained ICP >20-25 mmHg for more than 5-10 minutes is generally considered pathological and requires intervention.
• Epidemiology: Raised ICP is not a disease itself but a common final pathway of various neurological insults. It is a critical concern in pediatric neurocritical care, affecting children with traumatic brain injury (TBI), hydrocephalus, tumors, infections (meningitis, encephalitis), stroke, and metabolic encephalopathies. The incidence is directly tied to the underlying causes. For instance, TBI is a leading cause of morbidity and mortality in children, with raised ICP contributing significantly to adverse outcomes.
• Classification:
  • Acute vs. Chronic: Acute ICP elevation develops rapidly (hours to days), often life-threatening. Chronic ICP elevation develops slowly (weeks to months), such as in hydrocephalus or pseudotumor cerebri.
  • Communicating vs. Non-communicating Hydrocephalus: A common cause of raised ICP, classified based on CSF flow obstruction within or outside the ventricular system.
  • Primary vs. Secondary Brain Injury: Raised ICP is a component of secondary brain injury, exacerbating the initial insult.

Pathophysiology

• Mechanism: The Monro-Kellie doctrine states that the cranial vault is a rigid, non-expandable container, and its total volume (brain tissue, CSF, and blood) is constant. An increase in the volume of one component necessitates a decrease in one or both of the others to maintain constant ICP. When compensatory mechanisms (e.g., displacement of CSF into the spinal canal, reduction of cerebral blood volume) are exhausted, ICP rises steeply.
  • Cerebral Perfusion Pressure (CPP): CPP = Mean Arterial Pressure (MAP) - ICP. Maintaining adequate CPP (typically >50-60 mmHg in children) is crucial for preventing cerebral ischemia. Raised ICP directly compromises CPP.
  • Cerebral Autoregulation: The brain's ability to maintain constant cerebral blood flow (CBF) despite changes in MAP. This mechanism is often impaired in conditions leading to raised ICP, making the brain more vulnerable to ischemia or hyperemia.
  • Causes of Increased Intracranial Volume:
    • Mass Lesions: Tumors, hematomas (epidural, subdural, intraparenchymal), abscesses.
    • Increased CSF Volume: Hydrocephalus (obstructive or communicating), impaired CSF absorption (e.g., meningitis, subarachnoid hemorrhage).
    • Increased Cerebral Blood Volume: Vasodilation (e.g., hypercapnia, hypoxia), impaired venous outflow (e.g., jugular vein compression, thrombosis).
    • Increased Brain Water Content (Edema):
      • Vasogenic Edema: Disruption of blood-brain barrier (e.g., tumor, infection, trauma), leading to extravasation of plasma into interstitial space.
      • Cytotoxic Edema: Cellular swelling due to energy failure (e.g., ischemia, hypoxia, intoxications), affecting neurons and glial cells.
      • Interstitial Edema (Hydrocephalic Edema): Transependymal flow of CSF into periventricular white matter due to hydrocephalus.
• Risk Factors:
  • Age: Infants and young children are particularly vulnerable due to a pliable skull (until fontanelles close), which can temporarily mask signs, but also limited compensatory reserve.
  • Underlying Neurological Conditions: Hydrocephalus, brain tumors, AVMs, stroke.
  • Trauma: Severe TBI, abusive head trauma.
  • Infections: Meningitis, encephalitis, brain abscess.
  • Systemic Conditions: Sepsis, severe metabolic derangements (e.g., hepatic encephalopathy, Reye's syndrome), diabetic ketoacidosis (rarely, associated with cerebral edema), poisoning.
  • Genetic Syndromes: Craniosynostosis.
  • Vascular Malformations: Aneurysms, AVMs.
• Protective Factors:
  • Early Diagnosis and Intervention: Prompt recognition of signs and symptoms.
  • Optimal Hemodynamic Management: Maintaining adequate MAP and CPP.
  • Normocapnia/Mild Hypocapnia (controlled): Avoidance of significant hypercapnia.
  • Normothermia: Prevention of hyperthermia.
  • Seizure Control: Prevention of seizure-induced metabolic demands and cerebral vasodilation.

Clinical Presentation

Clinical presentation varies significantly with age, rapidity of ICP rise, and underlying cause.

Signs and Symptoms

• Cardinal Features:
  • Headache: Usually diffuse, worse in the morning, exacerbated by coughing, sneezing, or Valsalva maneuvers. May awaken the child from sleep. Often the first symptom in older children.
  • Vomiting: Projectile, often without nausea, especially in the morning.
  • Altered Mental Status: Irritability, lethargy, decreased level of consciousness (somnolence, stupor, coma).
  • Papilledema: Swelling of the optic disc due to pressure on the optic nerve. A late sign in infants, but may be present early in older children.
• Early Signs:
  • Infants (before fontanelle closure):
    • Irritability, high-pitched cry.
    • Poor feeding.
    • Lethargy.
    • Full, tense, or bulging fontanelle (especially when not crying).
    • Increased head circumference (crossing centile lines).
    • Split sutures (diastasis of cranial sutures).
    • Prominent scalp veins.
    • Sunset eyes (downward deviation of the eyes with sclera visible above the iris).
  • Older Children:
    • Headache.
    • Vomiting.
    • Behavioral changes (irritability, apathy, decline in school performance).
    • Visual disturbances (transient obscurations of vision, diplopia due to abducens nerve palsy [CN VI]).
    • Dizziness.
    • Fatigue.
• Advanced Signs:
  • Cushing's Triad: Bradycardia, systemic hypertension (widening pulse pressure), and irregular respirations (e.g., Cheyne-Stokes). A classic but late and ominous sign indicating brainstem compression.
  • Pupillary Changes: Asymmetric, dilated, or non-reactive pupils, usually ipsilateral to a mass lesion, indicating uncal herniation. Bilateral fixed and dilated pupils indicate severe bilateral brainstem compression/ischemia.
  • Posturing: Decorticate (flexor) or Decerebrate (extensor) posturing, indicating severe brainstem dysfunction.
  • Absent Brainstem Reflexes: Loss of corneal, oculocephalic, or vestibulo-ocular reflexes.
  • Coma: Unresponsiveness to painful stimuli.
• Atypical Presentations:
  • Recurrent abdominal pain with headache.
  • Growth hormone deficiency (due to pituitary compression).
  • Precocious puberty.
  • Developmental delay or regression in infants.
  • New-onset seizures.

Physical Examination

• Inspection:
  • General Appearance: Level of consciousness (Glasgow Coma Scale/Pediatric GCS), alertness, responsiveness.
  • Head: Inspect for signs of trauma, scalp swelling, bruising.
  • Fontanelles: Assess for fullness, tension, or bulging.
  • Head Circumference: Measure and plot on growth charts; rapid increase is concerning.
  • Eyes:
    • Pupil size, symmetry, reactivity to light.
    • Eye movements (strabismus, nystagmus, sunsetting sign).
    • Funduscopic examination for papilledema (requires skilled examination, may be absent in acute cases).
  • Breathing Pattern: Assess rate, depth, rhythm (e.g., Cheyne-Stokes, ataxic).
• Palpation:
  • Fontanelles: Palpate gently for tension and bulging.
  • Sutures: Palpate for separation/diastasis.
  • Skull: Palpate for tenderness, step-offs from trauma.
• Special Tests:
  • Neurological Examination:
    • Cranial Nerves: Especially CN VI (abducens palsy causing diplopia) and CN III (oculomotor palsy causing dilated pupil, ptosis, and 'down and out' eye deviation in severe cases).
    • Motor Function: Muscle strength, tone, spontaneous movements, presence of posturing.
    • Sensory Function: Response to pain (if comatose).
    • Reflexes: Deep tendon reflexes, plantar responses.
  • Vital Signs: Monitor heart rate (bradycardia), blood pressure (hypertension), respiratory rate and pattern.
  • Oculocephalic Reflex (Doll's Eyes): In comatose patients (only after C-spine clearance), normal reflex shows eyes moving opposite to head turning. Abnormal or absent reflex indicates brainstem dysfunction.
  • Vestibulo-ocular Reflex (Caloric Reflex): Cold water irrigation in ear canal (after tympanic membrane inspection) normally causes eye deviation toward the irrigated ear in conscious patients; in comatose patients, tonic deviation indicates intact brainstem.

Diagnostic Approach

History Taking

• Key Questions:
  • Onset and Duration: Acute vs. gradual onset of symptoms? How long have symptoms been present?
  • Progression: Are symptoms worsening, improving, or static?
  • Character of Headache: Location, severity, quality, aggravating/alleviating factors, time of day.
  • Associated Symptoms: Nausea, vomiting (projectile?), visual changes (diplopia, blurred vision, transient obscurations), dizziness, lethargy, irritability, behavioral changes, seizures.
  • Trauma History: Recent head trauma (even minor falls in infants), non-accidental trauma concerns.
  • Infection: Fever, neck stiffness, recent illness, rash.
  • Past Medical History: Previous neurological conditions (hydrocephalus, shunt placement, brain tumor), systemic diseases, medications.
  • Developmental Milestones: Any regression or delay in infants/young children.
• Red Flags:
  • Acute onset of severe headache ("worst headache of life").
  • Rapid decline in level of consciousness.
  • New-onset seizures.
  • Focal neurological deficits.
  • Cushing's triad.
  • Fixed and dilated pupils.
  • History of head trauma, especially with loss of consciousness or amnesia.
  • Bulging fontanelle in an infant.

Laboratory Tests

• First-Line:
  • Complete Blood Count (CBC): To rule out infection (e.g., meningitis) or anemia.
  • Electrolytes (Na, K, Cl, HCO3), Glucose, BUN, Creatinine: To assess for metabolic disturbances (e.g., hyponatremia in SIADH, hyperglycemia, DKA).
  • Coagulation Profile (PT/INR, PTT): Essential before any invasive procedures or if intracranial hemorrhage is suspected.
  • Arterial Blood Gas (ABG): To assess oxygenation and ventilation status (PaCO2 target), acid-base balance.
  • Blood Culture: If infection is suspected.
• Confirmatory:
  • Lumbar Puncture (LP): Contraindicated in the setting of suspected or confirmed raised ICP due to risk of herniation. Only perform after ruling out mass lesions/hydrocephalus via imaging, or if LP is critical for diagnosis (e.g., suspected meningitis with normal imaging). If performed, opening pressure measurement is crucial. CSF analysis (cell count, protein, glucose, culture) if infection is suspected and LP is deemed safe.
  • Serum Osmolality: Useful when managing fluid balance or suspected SIADH/DI.
  • Toxicology Screen: If poisoning/ingestion is suspected.
• Monitoring:
  • Repeat ABG, electrolytes, glucose, serum osmolality as clinically indicated based on management strategies.

Imaging

• Recommended:
  • Computed Tomography (CT) Scan of the Head (non-contrast):
    • Initial imaging study of choice in acute settings (e.g., trauma, acute neurological decline, suspected hemorrhage or mass).
    • Rapidly identifies mass lesions (hematoma, tumor, abscess), hydrocephalus, cerebral edema, effacement of sulci/cisterns, and midline shift.
    • Indications: Any child with suspected acute raised ICP, significant head trauma, unexplained altered mental status, focal neurological deficits.
  • Magnetic Resonance Imaging (MRI) of the Brain:
    • Superior for detailed brain parenchymal evaluation, detecting subtle lesions, demyelination, posterior fossa lesions, and assessing CSF flow dynamics.
    • Recommended for chronic or subacute raised ICP, unexplained headaches, papilledema without acute findings on CT, suspected congenital anomalies, or when CT is equivocal.
    • May include MR venography (MRV) if cerebral venous sinus thrombosis is suspected.
• Advanced:
  • CT Angiography (CTA) or MR Angiography (MRA): To evaluate vascular anomalies (aneurysms, AVMs) or large vessel occlusions.
  • Conventional Angiography: Gold standard for detailed vascular imaging, typically performed after non-invasive studies.

Management

The goal of management is to reduce ICP, maintain adequate cerebral perfusion pressure (CPP), and prevent secondary brain injury.

Acute Management

• Immediate (within minutes):
  • A-B-C Assessment & Stabilization:
    • Airway: Secure airway. Intubation and mechanical ventilation often required in severe cases (GCS ≤8, signs of herniation).
    • Breathing: Ensure adequate oxygenation (target SpO2 >95%) and ventilation. Avoid hypercapnia (PaCO2 <35 mmHg) but prevent excessive hypocapnia (PaCO2 <25 mmHg) as it causes cerebral vasoconstriction and can reduce CBF significantly. Maintain PaCO2 30-35 mmHg initially for acute ICP control; lower to 25-30 mmHg only for brief periods (minutes to hours) in imminent herniation.
    • Circulation: Maintain systemic blood pressure to ensure adequate CPP. Administer IV fluids (isotonic crystalloids, e.g., 0.9% NaCl). Vasopressors (e.g., norepinephrine) may be needed to support MAP. Target CPP >50-60 mmHg (individualize based on age/pathology).
• Stabilization (within the first hour):
  • Head Elevation: Elevate the head of the bed to 30 degrees to promote venous drainage, ensure neck is midline to avoid jugular vein compression.
  • Sedation and Analgesia: Control pain and agitation to prevent increases in ICP from noxious stimuli, coughing, or straining. Fentanyl or midazolam are commonly used; continuous infusions may be required. Avoid agents that cause hypotension or cerebral vasodilation (e.g., ketamine, though selective use by experts may occur).
  • Temperature Control: Maintain normothermia (36-37.5°C). Treat fever aggressively (antipyretics, cooling blankets) as hyperthermia increases cerebral metabolism and blood flow.
  • Seizure Prophylaxis: Administer antiepileptic drugs (AEDs) if clinical seizures occur or if there is a high risk (e.g., severe TBI, contusions, depressed skull fracture). Levetiracetam (20-60 mg/kg IV loading dose, then 10-20 mg/kg/dose BID) or phenytoin (15-20 mg/kg IV loading dose, then 5 mg/kg/day IV/PO in divided doses). Routine prophylactic AEDs without seizures are generally not recommended beyond 7 days in TBI.
  • Osmotic Therapy:
    • Mannitol: Reduces brain volume by creating an osmotic gradient, drawing water from brain parenchyma into intravascular space. Also reduces blood viscosity, improving CBF.
      • Dose: 0.25-1 g/kg IV bolus over 15-30 minutes. May repeat every 4-6 hours.
      • Monitoring: Serum osmolality (target <320 mOsm/kg), electrolytes, renal function.
    • Hypertonic Saline (HTS): More sustained effect than mannitol. Works similarly by creating an osmotic gradient. Also helps maintain intravascular volume.
      • Dose: 3% NaCl: 5-10 mL/kg IV bolus over 10-20 minutes. Can be used as a continuous infusion (e.g., 0.1-1 mL/kg/hr for 3%). Higher concentrations (7.5%, 23.4%) for smaller volumes.
      • Monitoring: Serum sodium (target 145-155 mEq/L, generally not exceeding 160 mEq/L), serum osmolality. Risk of central pontine myelinolysis if sodium corrected too rapidly.
  • CSF Drainage: If an ICP monitoring device (e.g., EVD) is in place, controlled drainage of CSF is highly effective for ICP reduction.
• Emergency (for impending herniation):
  • Rapid sequence intubation (if not already done).
  • Hyperventilation (PaCO2 25-30 mmHg) temporarily until definitive measures take effect (e.g., mannitol, HTS, surgery).
  • Immediate administration of Mannitol or Hypertonic Saline.
  • Urgent neurosurgical consultation for consideration of decompressive craniectomy or CSF drainage.

Chronic Management

• Pharmacological:
  • Diuretics (e.g., Acetazolamide): Used for chronic ICP elevation, especially in idiopathic intracranial hypertension (IIH) or certain types of hydrocephalus. Reduces CSF production.
    • Dose: 10-25 mg/kg/day divided QID (start low and titrate).
  • Topiramate: Increasingly used in IIH, may also reduce CSF production and aid in weight loss.
  • Steroids (e.g., Dexamethasone): Primarily for vasogenic edema associated with tumors or abscesses. Not recommended for TBI or stroke edema due to worse outcomes.
    • Dose: 0.25-1 mg/kg/day in divided doses, then taper.
• Non-pharmacological:
  • Treatment of Underlying Cause: Surgical resection of tumors, evacuation of hematomas, shunt placement for hydrocephalus, antibiotics for infections.
  • Weight Management: Crucial for children with IIH.
  • Dietary Modifications: Sodium restriction if fluid overloaded, seizure diet if epilepsy is present.
  • Physical Therapy/Occupational Therapy: For long-term neurological deficits.
• Monitoring:
  • Regular Clinical Neurological Assessments: Level of consciousness, focal deficits, fontanelle assessment, head circumference.
  • Serial Imaging: Follow-up CT/MRI to assess resolution of edema, tumor size, ventricular size.
  • ICP Monitoring: In select cases, for prolonged periods using external ventricular drains (EVD) or intraparenchymal catheters.
  • Ophthalmology Follow-up: Regular funduscopic exams for papilledema and visual field testing.

Treatment Algorithms (Simplified for Acute Management)

1. Suspected Raised ICP (Clinical Signs)
   • Initial Actions: ABCs, head elevation 30°, midline neck, sedation/analgesia, normothermia, ensure euvolemia (isotonic fluids).
   • Urgent Imaging: Non-contrast CT Head to rule out mass lesion/hydrocephalus/hemorrhage.
   • If Mass Lesion/Hydrocephalus identified:
     • Consult Neurosurgery urgently.
     • Hyperosmolar Therapy: Mannitol (0.5-1 g/kg IV) or Hypertonic Saline (3% NaCl, 5-10 mL/kg IV).
     • Consider brief hyperventilation (PaCO2 25-30 mmHg) if signs of herniation.
     • May need ICP monitoring (EVD) and CSF drainage.
     • Definitive Surgical Management (e.g., evacuation of hematoma, tumor resection, shunt placement).
   • If No Mass Lesion/Hydrocephalus, but ICP Signs persist/worsen (e.g., TBI, Encephalitis):
     • Consider ICP Monitoring: Place EVD or intraparenchymal probe.
     • Targeted Therapy based on ICP Values:
       • Tier 1:
         • Optimize ventilation (PaCO2 30-35 mmHg), oxygenation.
         • Sedation/Analgesia.
         • Head elevation.
         • Normothermia.
         • Intermittent CSF drainage (if EVD in place).
       • Tier 2 (if ICP >20-25 mmHg despite Tier 1):
         • Repeat hyperosmolar therapy (Mannitol/HTS).
         • Consider neuromonitoring (e.g., jugular venous oxygen saturation, brain tissue oxygenation).
         • Barbiturate Coma (e.g., Pentobarbital infusion, only in refractory cases with continuous EEG monitoring).
       • Tier 3 (if ICP refractory to Tiers 1 & 2):
         • Decompressive Craniectomy (surgical removal of skull bone flap to allow brain to swell).
         • Hypothermia (controversial, not standard practice outside of specific protocols).

Treatment Algorithm for Refractory Intracranial Hypertension (RIH)

1. Optimize all Tier 1 and Tier 2 therapies: Ensure adequate sedation, ventilation, normothermia, and maximal osmotic therapy.
2. Continuous ICP Monitoring: Essential.
3. Barbiturate Coma: Pentobarbital (loading dose 5-15 mg/kg IV, then 1-5 mg/kg/hr infusion) or Thiopental. Requires continuous EEG monitoring to achieve burst suppression or complete electrocerebral inactivity. Close monitoring of blood pressure (vasopressors often needed).
4. Decompressive Craniectomy (DC): If medical management fails and patient shows signs of cerebral edema with mass effect. This is a salvage procedure. Outcomes are variable, and may prevent death but not necessarily good neurological outcome.
5. Targeted CBF Management: In some centers, advanced monitoring (e.g., PbtO2, microdialysis) can guide therapies to optimize brain oxygenation and metabolism.

Complications

• Common:
  • Neurological deficits (motor weakness, sensory loss, cranial nerve palsies, cognitive impairment).
  • Hydrocephalus (communicating or non-communicating).
  • Seizures.
  • Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) or Diabetes Insipidus (DI) due to hypothalamic/pituitary dysfunction.
• Serious:
  • Cerebral Herniation: Life-threatening displacement of brain tissue under dural folds or through the foramen magnum.
    • Uncal Herniation: Uncus of temporal lobe compresses midbrain and CN III (ipsilateral fixed dilated pupil).
    • Tonsillar Herniation: Cerebellar tonsils through foramen magnum, compressing medulla (respiratory arrest, cardiovascular collapse).
  • Brain Ischemia/Infarction: Due to reduced CPP or vasospasm.
  • Intracranial Hemorrhage: Can be a cause or complication (e.g., from severe TBI or coagulopathy).
  • Brain Death: Irreversible cessation of all brain function.
• Long-term:
  • Neurocognitive impairment (memory, attention, executive function deficits).
  • Behavioral and psychological issues (irritability, mood swings).
  • Motor deficits (spasticity, ataxia).
  • Visual impairment.
  • Epilepsy.
  • Hormonal deficiencies (e.g., growth hormone, ADH).
  • Need for lifelong shunt management.

Prognosis

• Factors:
  • Underlying Cause: Prognosis is highly dependent on the etiology. For example, outcome for TBI is generally better than for severe anoxic brain injury.
  • Severity and Duration of ICP Elevation: Higher and more prolonged ICP elevation is associated with worse outcomes.
  • Presence of Herniation: Herniation syndromes are associated with very poor prognosis.
  • Age: Younger children (especially infants) may have greater plasticity but also more vulnerability to severe brain injury.
  • Neurological Status at Presentation: Initial GCS score is a strong predictor.
  • Presence of Comorbidities: Systemic illness, coagulopathy.
  • Rapidity of Intervention: Prompt and aggressive management can significantly improve outcomes.
• Survival: Varies widely. Severe TBI with refractory ICP may have mortality rates exceeding 50%. Conditions like idiopathic intracranial hypertension often have excellent survival but can result in visual loss if untreated.
• Quality of Life: Significant neurological sequelae (cognitive, motor, behavioral) are common, impacting quality of life and requiring extensive rehabilitation. Children may face challenges in school performance, social integration, and independent living.

Prevention

• Primary:
  • Injury Prevention: Helmet use for cycling/sports, car seat safety, childproofing homes, supervision to prevent falls and head trauma.
  • Vaccination: Immunization against common causes of meningitis (e.g., Hib, pneumococcus, meningococcus).
  • Management of Chronic Conditions: Early and effective management of hydrocephalus or brain tumors to prevent ICP rise.
• Secondary:
  • Early Recognition: Educating parents and healthcare providers about the signs and symptoms of raised ICP in children.
  • Prompt Medical Attention: Seeking immediate medical evaluation for any suspicious neurological symptoms or head injuries.
  • Rapid Diagnosis and Intervention: Timely neuroimaging and initiation of ICP-lowering therapies.
• Tertiary:
  • Preventing Complications: Aggressive management of ICP to prevent cerebral herniation and secondary brain injury.
  • Rehabilitation: Early and comprehensive rehabilitation services (physical, occupational, speech, neurodevelopmental therapy) to minimize long-term neurological deficits.
  • Long-term Follow-up: Regular neurological and developmental follow-up for children who have experienced significant ICP elevation.

Special Populations

• Pediatric:
  • Infants: Unique signs like bulging fontanelle, increased head circumference, split sutures. Less reliable verbal response in GCS. Higher risk of non-accidental trauma.
  • Toddlers/Preschoolers: Often present with irritability, lethargy, persistent vomiting. Difficulty localizing headache.
  • Adolescents: More likely to present with adult-like symptoms (headache, visual changes).
  • Physiological differences: Lower baseline BP, higher heart rate, more fragile cerebral vasculature compared to adults.
  • Response to Treatment: Children may respond differently to osmotic agents, requiring careful dosing and monitoring.
• Geriatric: Not applicable for this topic as the focus is children.
• Pregnancy: Not applicable for this topic as the focus is children.
• Comorbidities:
  • Coagulopathies: Increased risk of intracranial hemorrhage; requires careful management of coagulation before and during interventions.
  • Cardiac Disease: May impact ability to tolerate fluid shifts or hypotension from medications.
  • Renal Impairment: Caution with mannitol and hypertonic saline due to risk of fluid overload or electrolyte imbalances.
  • Diabetic Ketoacidosis (DKA): Cerebral edema is a rare but severe complication of DKA treatment; careful fluid and insulin management is critical to prevent rapid osmolar shifts.

Clinical Pearls

• Diagnostic:
  • "Sunset eyes" in infants are a highly suggestive sign of raised ICP.
  • Papilledema is a strong indicator but can be absent in acute ICP rise and requires skilled funduscopic examination.
  • Sudden onset of persistent, projectile vomiting without nausea should raise suspicion for ICP.
  • Any change in mental status in a child with a known or suspected neurological condition warrants immediate investigation.
  • Always consider abusive head trauma in infants and young children with unexplained neurological symptoms or head injuries.
• Treatment:
  • ABCs always first: Secure airway, optimize ventilation and oxygenation before any ICP-specific therapies.
  • Avoid Hypotension: Critical for maintaining CPP. Use isotonic fluids and vasopressors as needed.
  • Controlled Hyperventilation (PaCO2 25-30 mmHg): Reserve for acute herniation; it's a temporizing measure, not a sustained therapy.
  • Hypertonic Saline vs. Mannitol: HTS may be preferred in hypotensive patients or those requiring sustained ICP control; mannitol has faster onset but shorter duration.
  • ICP Monitoring Indications: GCS ≤ 8 after resuscitation, signs of herniation, or severe TBI in a sedated/paralyzed patient.
• Pitfalls:
  • Underestimating severity: Subtle signs in infants and young children can be easily missed or attributed to other conditions.
  • Delay in Imaging: Waiting too long for neuroimaging can delay definitive diagnosis and intervention.
  • Performing LP before Imaging: A dangerous mistake in suspected ICP, risking herniation.
  • Over-hyperventilation: Prolonged excessive hypocapnia (PaCO2 <25 mmHg) can cause severe cerebral ischemia.
  • Rapid Correction of Hyponatremia: Can lead to central pontine myelinolysis.
  • Not addressing underlying cause: Treating only the symptom (high ICP) without addressing the root cause will lead to recurrence.

Recent Updates

• Guidelines:
  • Brain Trauma Foundation (BTF) Guidelines for the Management of Severe Traumatic Brain Injury (TBI) in Infants, Children, and Adolescents (4th Edition): Emphasize maintaining CPP and ICP targets, judicious use of hyperosmolar therapy, and the role of decompressive craniectomy. These guidelines provide specific ICP targets (<20 mmHg generally) and CPP targets (40-65 mmHg depending on age/pathology).
  • Consensus Guidelines for Pediatric Idiopathic Intracranial Hypertension: Focus on weight management, acetazolamide, and surgical interventions for vision preservation.
• Evidence:
  • Ongoing research refining optimal CPP targets and the role of advanced neuromonitoring (e.g., brain tissue oxygenation, microdialysis) in guiding therapy for severe brain injury.
  • Debate continues regarding the precise indications and outcomes of decompressive craniectomy in pediatric TBI, with varying results across studies.
  • Increasing recognition of the long-term neurocognitive and behavioral sequelae even after successful acute ICP management, highlighting the need for comprehensive rehabilitation and follow-up.
• Controversies:
  • Optimal ICP and CPP targets: While general ranges exist, individualizing targets based on autoregulation status and multimodal monitoring is an area of active research.
  • Role of therapeutic hypothermia: While shown beneficial in adult cardiac arrest, its role in pediatric TBI and other causes of ICP remains controversial and not routinely recommended outside of research protocols.
  • Timing and extent of decompressive craniectomy: There is no universal consensus on when to perform DC and the optimal size/location of the craniectomy.

Key References

1. Adelson, P. D., et al. (2012). Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Pediatric Critical Care Medicine, 13(S1), S1-S82. (Note: A 4th edition update was published in 2019, available on the BTF website).
2. Kochanek, P. M., et al. (2019). Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition (2019). Brain Trauma Foundation. (Available at: www.braintrauma.org)
3. UpToDate. (Current as of most recent update). Evaluation and management of elevated intracranial pressure in children. (Subscription required for full access).
4. Greer, D. M., & Vaitkevicius, H. (2023). Overview of the management of elevated intracranial pressure in adults. UpToDate. (While adult-focused, principles apply with pediatric adaptations).
5. Brady, M. C., et al. (2020). Management of Idiopathic Intracranial Hypertension in Children: Consensus Guidelines. Pediatric Neurology, 107, 43-52.
6. Pediatric Advanced Life Support (PALS) guidelines, focusing on shock and respiratory failure management which are critical in supporting CPP. (American Heart Association/American Academy of Pediatrics).